Funding Rounds
Rivermark Medical, Inc.

Rivermark Medical October 2024 Series C Funding Round

Rivermark Medical, Inc.

Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $30.00M

Raised Date: 2024-10-10

Investors